Search Results - "Daumer, M"

Use of fermentation processes for improving the dissolution of phosphorus and its recovery from waste activated sludge by Bareha, Y., Saoudi, M., Santellani, A. C., Le Bihan, A., Picard, S., Mebarki, C., Cunha, M., Daumer, M.-L.

“…Recycling phosphorus from waste activated sludge has attracted a lot of interest to tackle the problem of phosphorus stocks depletion and the increase in food…”
Get full text

Onset of secondary progressive phase and long-term evolution of multiple sclerosis by Scalfari, Antonio, Neuhaus, Anneke, Daumer, Martin, Muraro, Paolo Antonio, Ebers, George Cornell

“…Objectives To assess factors affecting the rate of conversion to secondary progressive (SP) multiple sclerosis (MS) and its subsequent evolution. Methods Among…”
Get full text

Age and disability accumulation in multiple sclerosis by SCALFARI, A, NEUHAUS, A, DAUMER, M, EBERS, G. C, MURARO, P. A

“…We tested the hypothesis that age is a prognostic factor with respect to long-term accumulation of disability in multiple sclerosis (MS). Kaplan-Meier analysis…”
Get full text

The relationship of age with the clinical phenotype in multiple sclerosis by Scalfari, A, Lederer, C, Daumer, M, Nicholas, R, Ebers, GC, Muraro, PA

“…Background: The multiple sclerosis (MS) clinical course and relapses frequency before progression vary widely. Objective: To investigate the influence of age…”
Get full text

Ecological validity of walking capacity tests in multiple sclerosis by Stellmann, J P, Neuhaus, A, Götze, N, Briken, S, Lederer, C, Schimpl, M, Heesen, C, Daumer, M

“…Ecological validity implicates in how far clinical assessments refer to real life. Short clinical gait tests up to ten meters and 2- or 6-Minutes Walking Tests…”
Get full text

Technical and economical assessment of formic acid to recycle phosphorus from pig slurry by a combined acidification–precipitation process by Daumer, M.-L., Picard, S., Saint-Cast, P., Dabert, P.

“…Dissolution by acidification followed by a liquid/solid separation and precipitation of phosphorus from the liquid phase is one possibility to recycle…”
Get full text

CMA: a comprehensive Bioconductor package for supervised classification with high dimensional data by Slawski, M, Daumer, M, Boulesteix, A-L

“…For the last eight years, microarray-based classification has been a major topic in statistics, bioinformatics and biomedicine research. Traditional methods…”
Get full text

Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors by Martinez-Outschoorn, Ubaldo E., Pavlides, Stephanos, Whitaker-Menezes, Diana, Daumer, Kristin M., Milliman, Janet N., Chiavarina, Barbara, Migneco, Gemma, Witkiewicz, Agnieszka K., Martinez-Cantarin, Maria P., Flomenberg, Neal, Howell, Anthony, Pestell, Richard G., Lisanti, Michael P., Sotgia, Federica

“…Loss of stromal caveolin 1 (Cav-1) is a novel biomarker for cancer-associated fibroblasts that predicts poor clinical outcome in breast cancer and DCIS…”
Get full text

Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials by Walton, M.K., Cappelleri, J.C., Byrom, B., Goldsack, J.C., Eremenco, S., Harris, D., Potero, E., Patel, N., Flood, E., Daumer, M.

“…Mobile sensors offer enormous potential for the collection of informative clinical endpoints in clinical trials to support regulatory decision making and…”
Get full text

MRI as an outcome in multiple sclerosis clinical trials by DAUMER, M, NEUHAUS, A, MORRISSEY, S, HINTZEN, R, EBERS, G. C

“…T2-weighted and gadolinium enhanced T1-weighted MRI scans measure plaque burden and breakdown of the blood-brain barrier, respectively, in multiple sclerosis…”
Get full text

Disability as an outcome in MS clinical trials by EBERS, G. C, HEIGENHAUSER, L, DAUMER, M, LEDERER, C, NOSEWORTHY, J. H

“…Inferences about long-term effects of therapies in multiple sclerosis (MS) have been based on surrogate markers studied in short-term trials. Preventing…”
Get full text

HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis by Möller, F, Poettgen, J, Broemel, F, Neuhaus, A, Daumer, M, Heesen, C

“…Objective: To reassess the effect of modafinil, a wakefulness-promoting artificial psychostimulant, on fatigue and neuropsychological measures in patients with…”
Get full text

CAV1 Inhibits Metastatic Potential in Melanomas through Suppression of the Integrin/Src/FAK Signaling Pathway by TRIMMER, Casey, WHITAKER-MENEZES, Diana, BONUCCELLI, Gloria, MILLIMAN, Janet N, DAUMER, Kristin M, APLIN, Andrew E, PESTELL, Richard G, SOTGIA, Federica, LISANTI, Michael P, CAPOZZA, Franco

“…Caveolin-1 (CAV1) is the main structural component of caveolae, which are plasma membrane invaginations that participate in vesicular trafficking and signal…”
Get full text

Low clinical conversion rate in clinically isolated syndrome patients – diagnostic benefit of McDonald 2010 criteria? by Rosenkranz, S. C., Kaulen, B., Neuhaus, A., Siemonsen, S., Köpke, S., Daumer, M., Stellmann, J.‐P., Heesen, C.

“…Background and purpose New diagnostic criteria of multiple sclerosis (MS) increase the number of patients being diagnosed with MS whilst a substantial part…”
Get full text

The Sylvia Lawry Centre for Multiple Sclerosis Research (SLCMSR)––Critical review facing the 20 anniversary by Heesen, C, Magyari, M, Stellmann, JP, Lederer, C, Giovannoni, G, Scalfari, A, Daumer, M

“…•SLCMSR challenged established outcome parameters in MS.•Sustained increase of EDSS appeared to be an invalid outcome for clinical trials.•SLCMSR contributed…”
Get full text

MRI T2 lesion burden in multiple sclerosis : A plateauing relationship with clinical disability by LI, D. K. B, HELD, U, WOLINSKY, J. S, FILIPPI, M, PETKAU, J, DAUMER, M, BARKHOF, F, FAZEKAS, F, FRANK, J. A, KAPPOS, L, MILLER, D. H, SIMON, J. H

“…Previous studies have shown only modest correlation between multiple sclerosis (MS) lesions on MRI and clinical disability. To investigate the relationship…”
Get full text

Caveolin-1 (P132L), a Common Breast Cancer Mutation, Confers Mammary Cell Invasiveness and Defines a Novel Stem Cell/Metastasis-Associated Gene Signature by Bonuccelli, Gloria, Casimiro, Mathew C, Sotgia, Federica, Wang, Chenguang, Liu, Manran, Katiyar, Sanjay, Zhou, Jie, Dew, Elliott, Capozza, Franco, Daumer, Kristin M, Minetti, Carlo, Milliman, Janet N, Alpy, Fabien, Rio, Marie-Christine, Tomasetto, Catherine, Mercier, Isabelle, Flomenberg, Neal, Frank, Philippe G, Pestell, Richard G, Lisanti, Michael P

“…Here we used the Met-1 cell line in an orthotopic transplantation model in FVB/N mice to dissect the role of the Cav-1(P132L) mutation in human breast cancer…”
Get full text

Evaluating Microarray-based Classifiers: An Overview by Boulesteix, A.-L., Strobl, C., Augustin, T., Daumer, M.

“…A.-L. Boulesteix1, C. Strobl2, T. Augustin2 and M. Daumer1 1Sylvia Lawry Centre for MS Research (SLC), Hohenlindenerstr. 1, 81677 Munich, Germany. 2Department…”
Get full text

Evolution of raltegravir resistance during therapy by Sichtig, Nadine, Sierra, Saleta, Kaiser, Rolf, Däumer, Martin, Reuter, Stefan, Schülter, Eugen, Altmann, Andre, Fätkenheuer, Gerd, Dittmer, Ulf, Pfister, Herbert, Esser, Stefan

“…Objectives We investigated the prevalence of raltegravir resistance-associated mutations at baseline and their evolution during raltegravir therapy in patients…”
Get full text

Onset of secondary progression and long-term prognosis in multiple sclerosis by Scalfari, A, Neuhaus, A, Daumer, M, Muraro, P, Ebers, G

Get full text